Loading clinical trials...
Loading clinical trials...
Hepatocellular carcinoma (HCC) is a common cancer worldwide and a leading cause of cancer-related death. The majority of participants first presenting with HCC have advanced unresectable or metastatic...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AbbVie
NCT07610551 · HCC - Hepatocellular Carcinoma
NCT07012798 · Hepatocellular Carcinoma (HCC)
NCT06902246 · Unresectable Hepatocellular Carcinoma, Hepatocellular Carcinoma
NCT07478302 · Advanced Unresectable Hepatocellular Carcinoma
NCT07322848 · Hepatocellular Carcinoma (HCC), TACE, and more
City of Hope /ID# 261468
Duarte, California
City of Hope at Orange County Lennar Foundation Cancer Center /ID# 261669
Irvine, California
UC Irvine /ID# 255673
Orange, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions